Analysis: Nobel Says to Korea Nuke Players: We are Watching

The International Campaign to Abolish Nuclear Weapons (ICAN) was awarded the Nobel Prize for Peace. (Reuters)
The International Campaign to Abolish Nuclear Weapons (ICAN) was awarded the Nobel Prize for Peace. (Reuters)
TT

Analysis: Nobel Says to Korea Nuke Players: We are Watching

The International Campaign to Abolish Nuclear Weapons (ICAN) was awarded the Nobel Prize for Peace. (Reuters)
The International Campaign to Abolish Nuclear Weapons (ICAN) was awarded the Nobel Prize for Peace. (Reuters)

They couldn't award it to Kim Jong Un or Donald Trump. That much was certain.

But the granting of the Nobel Peace Prize to the International Campaign to Abolish Nuclear Weapons opened itself to a clear interpretation across Asia: When it comes to the nuclear-saturated war of words on the Korean Peninsula, attention must be paid and treaties must be signed. And it must be done in a preventative way, at top speed, before something happens that can't be undone, said an Associated Press report.

Looming in the background of the award announcement Friday was the sometimes scalding, sometimes tepid, never silent geopolitical scuffle this year between the young leader of the third-generation Pyongyang regime and the always voluble president of the United States.

Even the Nobel committee's language keyed in on that. It sounded like a plaintive cry to push parties to the negotiating table — to fix something that's already cracked before it's completely, irreversibly shattered.

The head of the group listed an assortment of the world's nuclear nations when she spoke after the win. But it was easy to find significance in the two she mentioned before all others — North Korea and the United States.

And this was the immediate assessment from a Nobel historian: "The panel wants to send a signal to North Korea and the US that they need to go into negotiations." The prize, Oeivind Stenersen suggested, was also "coded support" of the Iran nuclear deal.

This year's Geneva-based winner, known as ICAN, was cited "for its work to draw attention to the catastrophic humanitarian consequences of any use of nuclear weapons and for its ground-breaking efforts to achieve a treaty-based prohibition of such weapons."

From the vantage point of the Korean Peninsula and its surrounding countries, where people shudder weekly at volleys of intemperate words and missile or bomb tests, such a treaty seems a distant dream. And few of the key players seem anywhere near a Nobel Peace Prize, said the AP.

North Korea just conducted its sixth and by far largest nuclear test, moving closer to its goal of mounting a nuclear warhead on an intercontinental ballistic missile. It has repeatedly threatened to obliterate the United States from the map.

Such bellicose language from the North is common. It has spent years issuing over-the-top dispatches through its propaganda apparatus promising to destroy the United States.

In recent months, however, Pyongyang's invective has been matched almost blow by blow for the first time by equally aggressive language from Washington under the Trump administration, or at least Trump himself. The US president has shown no hesitation in cutting through the niceties of diplomatic lingo to excoriate the North and threaten to wipe it out of existence.

He has dubbed Kim "Little Rocket Man" and said his regime may not be long for this world. The US, of course, has one of the world's largest nuclear arsenals, even after significant reductions since the Cold War. It remains the only nation on the planet to use nuclear weapons during a war.

In the past four weeks alone, Trump has used words like these, in a recent tweet: "Just heard Foreign Minister of North Korea speak at UN If he echoes thoughts of Little Rocket Man, they won't be around much longer!"

And Kim, who bestowed upon Trump the rarely used insult "dotard" and pronounced him senile, has used words like these:

"Now that Trump has denied the existence of and insulted me and my country in front of the eyes of the world and made the most ferocious declaration of a war in history that he would destroy (North Korea), we will consider with seriousness exercising of a corresponding, highest level of hard-line countermeasure in history."

Public posturing, sure. But not exactly language that points the way toward common ground, either.
The tension in word and deed between Washington and Pyongyang has faded slightly in recent days as the in-the-moment news cycle marches forward, but history shows that to be temporary. Another early-morning missile test, another intemperate remark or worse will put it right back on center stage.

The awarding of the $1.1 million prize to ICAN helps that happen, too, though even the group's executive director, Beatrice Fihn, said she "worried it was a prank at first" when she got the call from the Nobel committee.

Against this backdrop — and in Northeast Asia, a region that remains the only place where nuclear weapons were used against a civilian population during a war — the awarding of the Nobel Peace Prize in this manner implies one key point.

The influential body, which often uses the prize to set the agenda of where the light gets shone, is saying to Kim Jong Un and Donald Trump, among others: We've got our eye on you, and the world needs to look harder, too.



New Mpox Strain Is Changing Fast; African Scientists Are ‘Working Blind’ to Respond 

Dr. Robert Musole, medical director of the Kavumu hospital (R) consults an infant suffering from a severe form of mpox at the Kavumu hospital, 30 km north of Bukavu in eastern Democratic Republic of Congo, August 24, 2024. (AFP)
Dr. Robert Musole, medical director of the Kavumu hospital (R) consults an infant suffering from a severe form of mpox at the Kavumu hospital, 30 km north of Bukavu in eastern Democratic Republic of Congo, August 24, 2024. (AFP)
TT

New Mpox Strain Is Changing Fast; African Scientists Are ‘Working Blind’ to Respond 

Dr. Robert Musole, medical director of the Kavumu hospital (R) consults an infant suffering from a severe form of mpox at the Kavumu hospital, 30 km north of Bukavu in eastern Democratic Republic of Congo, August 24, 2024. (AFP)
Dr. Robert Musole, medical director of the Kavumu hospital (R) consults an infant suffering from a severe form of mpox at the Kavumu hospital, 30 km north of Bukavu in eastern Democratic Republic of Congo, August 24, 2024. (AFP)

Scientists studying the new mpox strain that has spread out of Democratic Republic of Congo say the virus is changing faster than expected, and often in areas where experts lack the funding and equipment to properly track it.

That means there are numerous unknowns about the virus itself, its severity and how it is transmitting, complicating the response, half a dozen scientists in Africa, Europe and the United States told Reuters.

Mpox, formerly known as monkeypox, has been a public health problem in parts of Africa since 1970, but received little global attention until it surged internationally in 2022, prompting the World Health Organization to declare a global health emergency. That declaration ended 10 months later.

A new strain of the virus, known as clade Ib, has the world's attention again after the WHO declared a new health emergency.

The strain is a mutated version of clade I, a form of mpox spread by contact with infected animals that has been endemic in Congo for decades. Mpox typically causes flu-like symptoms and pus-filled lesions and can kill.

Congo has had more than 18,000 suspected clade I and clade Ib mpox cases and 615 deaths this year, according to the WHO. There have also been 222 confirmed clade Ib cases in four African countries in the last month, plus a case each in Sweden and Thailand in people with a travel history in Africa.

"I worry that in Africa, we are working blindly," said Dr. Dimie Ogoina, an infectious diseases expert at Niger Delta University Hospital in Nigeria who chairs the WHO's mpox emergency committee. He first raised the alarm about potential sexual transmission of mpox in 2017, now an accepted route of spread for the virus.

"We don’t understand our outbreak very well, and if we don't understand our outbreak very well, we will have difficulty addressing the problem in terms of transmission dynamics, the severity of the disease, risk factors of the disease," Ogoina said. "And I worry about the fact that the virus seems to be mutating and producing new strains."

He said it took clade IIb in Nigeria five years or more to evolve enough for sustained spread among humans, sparking the 2022 global outbreak. Clade Ib has done the same thing in less than a year.

MUTATING 'MORE RAPIDLY'

Mpox is an orthopoxvirus, from the family that causes smallpox. Population-wide protection from a global smallpox vaccine campaign 50 years ago has waned, as the vaccinating stopped when the disease was eradicated.

Genetic sequencing of clade Ib infections, which the WHO estimates emerged mid-September 2023, show they carry a mutation known as APOBEC3, a signature of adaptation in humans.

The virus that causes mpox has typically been fairly stable and slow to mutate, but APOBEC-driven mutations can accelerate viral evolution, said Dr. Miguel Paredes, who is studying the evolution of mpox and other viruses at Fred Hutchison Cancer Center in Seattle.

"All the human-to-human cases of mpox have this APOBEC signature of mutations, which means that it's mutating a little bit more rapidly than we would expect," he said.

Paredes and other scientists said a response was complicated by several mpox outbreaks happening at once.

In the past, mpox was predominantly acquired through human contact with infected animals. That is still driving a rise in Congo in clade I cases – also known as clade Ia - likely due in part to deforestation and increased consumption of bushmeat, scientists said.

The mutated versions, clade Ib and IIb, can now essentially be considered a sexually transmitted disease, said Dr. Salim Abdool Karim, a South African epidemiologist and chair of the Africa CDC’s mpox advisory committee. Most of the mutated clade Ib cases are among adults, driven at first by an epidemic among female sex workers in South Kivu, Congo.

The virus also can spread through close contact with an infected person, which is likely how clusters of children have been infected with clade Ib, particularly in Burundi and in eastern Congo’s displacement camps, where crowded living conditions may be contributing.

Children, pregnant women and people with weakened immune systems or other illnesses may be at greater risk of serious mpox disease and death, say the WHO and mpox scientists.

Clade I has typically caused more severe disease, with fatality rates of 4%-11%, compared to around 1% for clade II. Ogoina said data from Congo suggests few have died of the new Ib version, but he feared some data is being mixed up.

More research is urgently needed, but three teams tracking mpox outbreaks in Africa say they cannot even access chemicals needed for diagnostic tests. Clade Ib can also be missed by some diagnostic tests.

Planning a response, including vaccination strategies, without this is difficult, the scientists said.

Karim said around half of cases in eastern Congo, where Ib is particularly prevalent, are only being diagnosed by doctors, with no laboratory confirmation.

Getting samples to labs is difficult because the healthcare system is already under pressure, he said. And around 750,000 people have been displaced amid fighting between the M23 rebel group and the government.

Many African laboratories cannot get the supplies they need, said Dr. Emmanuel Nakoune, an mpox expert at the Institut Pasteur in Bangui, Central African Republic, which also has clade Ia cases.

"This is not a luxury," he said, but necessary to track deadly outbreaks.